MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0119023
Sunlife Pharmaceuticals Limited - pharma in Kalyan, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.04 Cr
▼ 34% YoY
Net profit · FY 2025
₹70,734
Net margin 0.7%
EBITDA · FY 2025
₹4.49 Lakh
EBITDA margin 4.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5.71 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Sunlife Pharmaceuticals Limited
Data last updated:
Sunlife Pharmaceuticals Limited is a public limited company based in Kalyan, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 November 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74990MH2009PLC197290. Its GSTIN is 27AANCS6299M1Z9 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.71 Lakh. It is led by directors including Priyanka Devendra Mishra and Devendra Harendranath Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 107 Globe Estate Plot No C9 MIDC Phase 1, New Kalyan Road Dombivli (E) Thane Maharashtra 421203 India, Maharashtra, India – 421203.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.04 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹70,734 (net margin 0.7%) and EBITDA of ₹4.49 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 9% over five years.
Sunlife Pharmaceuticals Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0119023). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunlifepharmaceuticals.com.
Company details
CIN U74990MH2009PLC197290
Registration Number 197290
Incorporation Date 24 November 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0119023
Key People
Priyanka Devendra Mishra Director Devendra Harendranath Mishra Director Bachchalal Jaisingh Yadawa Director Recognitions & Rankings of Sunlife Pharmaceuticals
Contact details
Sunlife Pharmaceuticals Limited's registered office is in Kalyan, Maharashtra. Its website is sunlifepharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address107 Globe Estate Plot No C9 MIDC Phase 1, New Kalyan Road Dombivli (E) Thane Maharashtra 421203 India, Maharashtra, India – 421203
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sunlife Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Sunlife Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sunlife Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Sunlife Pharmaceuticals Limited, buy the company report.
Financials of Sunlife Pharmaceuticals Limited
FY 2025 filings availableSunlife Pharmaceuticals Limited reported revenue of ₹1.04 Cr (down 34% YoY) for FY 2025.
Revenue · FY 2025
₹1.04 Cr ▼ 34%
Net profit · FY 2025
₹70,734 margin 0.7%
EBITDA · FY 2025
₹4.49 Lakh margin 4.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 34%
3 years · compounded
▲ 6%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 220%
3 years · compounded
▲ 94%
5 years · compounded
▲ 20%
Revenue fell 34% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 220% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹70,734 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunlife Pharmaceuticals Limited, buy the company report.
Board of directors of Sunlife Pharmaceuticals Limited
Sunlife Pharmaceuticals has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Devendra Mishra | Director | 01 Apr 2016 | 10 Years 7 Months | Current |
| Devendra Harendranath Mishra | Director | 01 Apr 2016 | 10 Years 7 Months | Current |
| Bachchalal Jaisingh Yadawa Also directs: S.B. Ren Industries LLP | Director | 12 Jan 2017 | 9 Years 9 Months | Current |
Auditor
Sunlife Pharmaceuticals Limited is audited by Amar Pandey & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Amar Pandey & Company | FY 2023 | 144710W |
Shareholding
The shareholding of Sunlife Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sunlife Pharmaceuticals Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sunlife Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunlife Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sunlife Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANCS6299M1Z9 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sunlife Pharmaceuticals Limited, buy the company report.
Recent activity
Sunlife Pharmaceuticals Limited has 16 board changes on record since 2010: 3 appointments and 13 cessations. The latest: Bachchalal Jaisingh Yadawa ceased to be Additional Director on 30 Sep 2017.
AGM
Sunlife Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sunlife Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Bachchalal Jaisingh Yadawa ceased to be Additional Director.
Ceased
Devendra Harendranath Mishra ceased to be Director.
Ceased
Priyanka Devendra Mishra ceased to be Director.
Appointed
Bachchalal Jaisingh Yadawa was appointed as Director.
Ceased
Chandramohan Krishna Shetty ceased to be Director.
Appointed
Devendra Harendranath Mishra was appointed as Director.
Ceased
Dinesh Brijlal Patil ceased to be Director.
Ceased
Jaiprakash Motilal Patel ceased to be Director.
Ceased
Jaysing Khandu Salve ceased to be Director.
Ceased
Mahendrakumar Rampravesh Yadav ceased to be Director.
7 earlier events are in the company report.
Frequently asked questions
Sunlife Pharmaceuticals is an active public limited company based in Kalyan, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 November 2009 (17+ years old) and is registered under CIN U74990MH2009PLC197290.
Sunlife Pharmaceuticals has 3 current directors:
- Priyanka Devendra Mishra - Director
- Devendra Harendranath Mishra - Director
- Bachchalal Jaisingh Yadawa - Director
The latest financial statements of Sunlife Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sunlife Pharmaceuticals is 27AANCS6299M1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sunlife Pharmaceuticals is U74990MH2009PLC197290. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunlife Pharmaceuticals was incorporated on 24 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Bachchalal Jaisingh Yadawa ceased to be Additional Director on 30 Sep 2017. Devendra Harendranath Mishra ceased to be Director on 29 Sep 2017. Priyanka Devendra Mishra ceased to be Director on 29 Sep 2017. Sunlife Pharmaceuticals has 16 board changes on record in total.
Yes, Sunlife Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0119023).
Sunlife Pharmaceuticals can be reached through the website sunlifepharmaceuticals.com. Its registered office is in Kalyan, Maharashtra, India.
The registered office of Sunlife Pharmaceuticals is at 107 Globe Estate Plot No C9 MIDC Phase 1, New Kalyan Road Dombivli E Thane Maharashtra 421203 India, Maharashtra, India – 421203.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages